LLY NYSE
Eli Lilly and Company
1W: +3.1%
1M: +8.1%
3M: +4.8%
YTD: +18.6%
1Y: +56.0%
3Y: +120.0%
5Y: +457.4%
$1,281.91
+2.77 (+0.22%)
After Hours: $1283.30 (+1.39, +0.11%)
Weekly Expected Move ±4.4%
$1162
$1218
$1273
$1329
$1385
Credit Risk of going bust: lower than 84% of companies Debt: 4.4% of company value Bonds: $1.28B held by 465 funds, 44 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $5.05 (down 99.6%), Eli Lilly and Company would be worth roughly what it owes.
Total debt $54.91B against a stock market value of $1.20T.
Distance to default 10.86 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $30.98B (short-term plus half of long-term), stock volatility 34.6%; Altman Z 8.56. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $5.05 (down 99.6%), Eli Lilly and Company would be worth roughly what it owes.
Total debt $54.91B against a stock market value of $1.20T.
Distance to default 10.86 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $30.98B (short-term plus half of long-term), stock volatility 34.6%; Altman Z 8.56. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.45
Bullish
7 bullish
7 neutral
0 bearish
Articles (24h)
14
Hourly Sentiment (24h)
Articles (11)
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
Is Merck Stock a Buy, Sell or Hold Ahead of Q3 Earnings?
Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 Earnings
1,400 Eli Lilly and Company $LLY Shares Purchased by Canton Hathaway LLC
Eli Lilly and Company $LLY Shares Bought by Capital Investment Advisors LLC
Eli Lilly and Company $LLY Stock: BG Investment Services LLC Raises Position
Eli Lilly and Company $LLY Stock: Gibbs Wealth Management Boosts Position
Eli Lilly and Company $LLY Stock: Citizens Financial Group Inc. RI Reduces Holdings
Ascent Wealth Partners LLC Makes New $10.57 Million Investment in Eli Lilly and Company $LLY
Eli Lilly defeats Novo Nordisk attempt to halt weight-loss drug ads
0.31
Bullish
27 bullish
28 neutral
6 bearish
Articles (7d)
61
Daily Sentiment (7 Days)
Articles (100)
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
Is Merck Stock a Buy, Sell or Hold Ahead of Q3 Earnings?
Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 Earnings
1,400 Eli Lilly and Company $LLY Shares Purchased by Canton Hathaway LLC
Eli Lilly and Company $LLY Shares Bought by Capital Investment Advisors LLC
Eli Lilly and Company $LLY Stock: BG Investment Services LLC Raises Position
Eli Lilly and Company $LLY Stock: Gibbs Wealth Management Boosts Position
Eli Lilly and Company $LLY Stock: Citizens Financial Group Inc. RI Reduces Holdings
Ascent Wealth Partners LLC Makes New $10.57 Million Investment in Eli Lilly and Company $LLY
Eli Lilly defeats Novo Nordisk attempt to halt weight-loss drug ads
Don't Miss This Week's 5 Most Important Earnings Charts
Eli Lilly declares $1.73 dividend
AI Headlines Pile Up as Wall Street Navigates a Volatile Week
4 stocks to watch on Monday: VZ, META, LLY, and XYZ
Should You Buy Viking Therapeutics Stock Ahead of Q3 Results?
LLY vs. MRK: Which Stock Offers the More Compelling Investment Case?
Lilly (LLY) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
557 Eli Lilly and Company $LLY Shares Purchased by Yousif Capital Management LLC
Eli Lilly reports promising lung cancer drug results
Should You Buy Bristol Myers Squibb While It Trades Below 10 Times Forward Earnings?
Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more
3,956 Eli Lilly and Company $LLY Shares Sold by Brookstone Capital Management
Eli Lilly and Company $LLY Shares Sold by Adams Diversified Equity Fund Inc.
The Nasdaq Just Had Its Worst Day in 4 Months. Here's the Level That Would Signal a Correction, and What History Says Investors Can Do About It.
Eli Lilly releases promising early-stage data on ADC for ovarian cancer
Eli Lilly and Company $LLY Shares Sold by Essential Planning LLC.
7,473 Eli Lilly and Company $LLY Shares Sold by Halter Ferguson Financial Inc.
Axxcess Wealth Management LLC Sells 12,282 Shares of Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Stock Purchased by Crossmark Global Holdings Inc.
Eli Lilly and Company $LLY Stock Purchased by Crossmark Global Holdings Inc.
Eli Lilly and Company $LLY Shares Newly Purchased by Fifth Third Securities Inc.
3 Portfolio-Worthy Stocks Hitting 52-Week Highs: AAPL, LLY & KO
2 Growth Stocks to Hold for the Next Decade (Hint: These Aren’t AI Stocks)
Catalyst watch: Fed meeting, earnings blitz, Oracle AI event, and a pure-play hockey stock
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
J&J Stock Reclaims 50-Day SMA: Is it Time to Buy, Sell or Hold?
Incyte Gears Up to Report Q3 Earnings: Will Results Disappoint?
Eli Lilly and Company $LLY Stock: Carnegie Investment Counsel Increases Stake
757 Shares in Eli Lilly and Company $LLY Acquired by Englebert Financial Advisers LLC
Cushing Capital Partners LLC Buys New Holdings in Eli Lilly and Company $LLY
Integrated Advisors Network LLC Sells 1,746 Shares of Eli Lilly and Company $LLY
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?
Roche's 9M 2026 Sales Rise on Strong Drug Demand, Pipeline Advances
NVO vs. VKTX: Which Obesity Stock Could Deliver Bigger Gains?
Earnings Preview: Eli Lilly (LLY) Q3 Earnings Expected to Decline
Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?
449 Shares in Eli Lilly and Company $LLY Purchased by Boyd Wealth Management LLC
Eli Lilly and Company $LLY Stock: Bank Pictet & Cie Europe AG Reduces Holdings
Eli Lilly and Company $LLY Stock Purchased by Diversify Advisory Services LLC
Where Will Novo Stock Be in 10 Years?
Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026
How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
Eli Lilly and Company $LLY Stock Holdings Trimmed by Grandview Asset Management LLC
Eli Lilly and Company $LLY Stock: Focused Alpha LLC Boosts Holdings
Eli Lilly and Company $LLY Stock: Focused Alpha LLC Boosts Holdings
Here's What I'm Planning With My Eli Lilly Position
Novo's CagriSema leads to 25% weight loss in women
XLV touches a new high, hitting overbought territory
Stock Market Midday, Oct. 20: Blue Chips Rally, Eli Lilly Gains 5%
Eli Lilly hits all-time high share price
Lilly, METiS ink AI-driven drug delivery deal worth up to $1.1B
Can Viking Therapeutics Carve Out a Place in the Obesity Market?
432 Shares of Eli Lilly and Company $LLY Purchased by Prospera Capital Management LLC
Eli Lilly and Company $LLY Stock: Prairie Advisory LLC Increases Stake
Eli Lilly and Company $LLY Holdings Increased by James Hambro & Partners LLP
Eli Lilly and Company $LLY Shares Bought by Foguth Wealth Management LLC.
2,030 Eli Lilly and Company $LLY Shares Sold by BDF Gestion
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
Is Eli Lilly Stock a Buy Right Now?
Roche pauses German investments over healthcare reforms
Oppenheimer updates its top 50 buy list, rotating away from big banks
How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
Lilly to expand Omvoh for pediatric ulcerative colitis after late-stage trial win
SteelPeak Wealth LLC Acquires 4,322 Shares of Eli Lilly and Company $LLY
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
IFP Advisors Inc Buys 705 Shares of Eli Lilly and Company $LLY
Gemmer Asset Management LLC Purchases 402 Shares of Eli Lilly and Company $LLY
Eli Lilly and Company $LLY Stock Bought by Forbes J M & Co. LLP
Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It
What a Mixed Midterm Result Could Mean for These 2 Health Care ETFs
Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter.
Novo Trades at Less Than 12 Times Earnings. Is This the Buying Opportunity of the Decade?
Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus
Ken Griffin Increased His Position in This Dividend King by a Whopping 546% in Q2. Here's Why It's Still a Buy.
Eli Lilly and Company $LLY Stock: Cyndeo Wealth Partners LLC Trims Holdings
Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
1,151 Eli Lilly and Company $LLY Shares Bought by Barlow Wealth Partners LLC
If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys
Eli Lilly and Company $LLY Stock Bought by Annex Advisory Services LLC
Forget Zepbound: 3 Newer Drugs That Could Power Eli Lilly's Next Leg Higher
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
Lilly, Pfizer, J&J among winners of EU drug recommendations this month
Eli Lilly's Biggest Shareholder Is Selling $347 Million of Stock. Should You Sell Too?
Lilly wins EU backing for Foundayo weight-loss pill
Stock Split Watch: Is Eli Lilly Next?
Meet the Low-Cost Vanguard ETF With Taiwan Semiconductor, Samsung Electronics, SK Hynix, and ASML as Its 4 Largest Holdings